Summit Financial’s BlackRock Health Sciences Trust BME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.85M Buy
48,042
+4,412
+10% +$182K 0.02% 598
2025
Q4
$1.79M Buy
43,630
+9,131
+26% +$361K 0.03% 520
2025
Q3
$1.28M Buy
+34,499
New +$1.25M 0.02% 581

Other funds holding BME

Summit Financial's BME Position: Q1 2026 in Review

Summit Financial increased its BlackRock Health Sciences Trust (BME) stake by 10% in Q1 2026, buying an estimated $182K and bringing the position to 48,042 shares worth $1.85M. The position accounts for 0.02% of the portfolio, ranked #598.

Summit Financial first reported a position in BME in Q3 2025 and has held it in 3 quarters since. 76 funds tracked by Wall St. Rank hold BME as of Q1 2026.

  • Summit Financial held 48,042 shares of BlackRock Health Sciences Trust worth $1.85M as of Q1 2026.
  • Summit Financial bought 4,412 BlackRock Health Sciences Trust shares in Q1 2026, an estimated $182K.
  • BlackRock Health Sciences Trust made up 0.02% of Summit Financial's portfolio in Q1 2026, its #598 holding.
  • Summit Financial first reported a position in BlackRock Health Sciences Trust in Q3 2025 and has held it in 3 quarters since.
  • 76 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q1 2026.

Based on Summit Financial's 13F filing for Q1 2026, filed 15 May 2026.